会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • ADIPONECTIN RECEPTOR FRAGMENTS AND METHODS OF USE
    • ADIPONECTIN受体片段和使用方法
    • US20090143275A1
    • 2009-06-04
    • US12169983
    • 2008-07-09
    • Michael J. PugiaRui Ma
    • Michael J. PugiaRui Ma
    • A61K38/02A61P3/10A61P35/00
    • C07K14/72A61K38/00
    • Methods are disclosed of treating diabetes, abnormal adipocyte activity, and insulin resistance using C-terminal fragments of adiponectin receptor R1. Methods of causing the secretion of insulin in healthy and diabetic patients using C-terminal fragments of adiponectin receptor R1 are also disclosed. In addition, methods are disclosed of increasing the insulin levels in healthy patients using C-terminal fragments of adiponectin receptor R1. In addition, methods of treating abnormal adipocyte activity, treating metabolic syndrome, causing insulin secretion, increasing insulin levels, inhibiting insulin degradation enzyme, treating Alzheimer's disease, treating cardiovascular disease associated with adiponectin levels, inhibiting ADAM-17 enzyme, treating a condition associated with TNF-alpha, and treating a condition associated with HER2-neu are disclosed. Compositions, dosage forms, and kits are also disclosed.
    • 公开了使用脂联素受体R1的C末端片段治疗糖尿病,异常脂肪细胞活性和胰岛素抵抗的方法。 还公开了使用脂联素受体R1的C末端片段在健康和糖尿病患者中分泌胰岛素的方法。 此外,公开了使用脂联素受体R1的C末端片段增加健康患者的胰岛素水平的方法。 另外,处理异常脂肪细胞活性,治疗代谢综合征,引起胰岛素分泌,增加胰岛素水平,抑制胰岛素降解酶,治疗阿尔茨海默氏病,治疗与脂联素水平相关的心血管疾病,抑制ADAM-17酶,治疗与 公开了TNF-α和治疗与HER2-neu相关的病症。 还公开了组合物,剂型和试剂盒。
    • 10. 发明授权
    • Method of assaying for peroxidatively active substances
    • 测定过氧化物质活性物质的方法
    • US5362633A
    • 1994-11-08
    • US187384
    • 1994-01-27
    • Michael J. Pugia
    • Michael J. Pugia
    • G01N31/00C12Q1/28G01N31/22G01N33/50G01N33/52G01N33/72C12Q1/26C12Q1/56
    • G01N33/521C12Q1/28G01N33/725C12Q2326/12Y10S436/904
    • A method of determining the presence or concentration of a peroxidatively active substance, such as hemoglobin, in a test sample is disclosed. The method comprises contacting the test sample with an indicator reagent composition which interacts with the peroxidatively active substance to produce a measurable or detecable color change. The indicator reagent composition comprises a redox indicator dye, a hydroperoxide, a ferric ion and a phosphorous compound having the formula ##STR1## wherein R.sub.1 or R.sub.2 are certain substituted or an unsubstituted aromatic moieties or certain polyhydric compounds, and wherein X is O, S or NH. The assay can be performed in wet phase or the composition can be incorporated into a carrier matrix. The method provides a more accurate and trustworthy assay of a test sample for a peroxidatively active substance and is especially useful in the assay of urine for occult blood.
    • 公开了一种测定样品中过氧化物质活性物质如血红蛋白的存在或浓度的方法。 该方法包括使测试样品与指示剂组合物接触,所述指示剂组合物与过氧化物质活性物质相互作用以产生可测量或可检测的颜色变化。 指示剂组合物包含氧化还原指示剂染料,氢过氧化物,三价铁离子和具有式“IMAGE”的磷化合物,其中R1或R2是某些取代的或未被取代的芳族部分或某些多羟基化合物,并且其中X是O,S 或NH。 该测定可以在湿相中进行,或者该组合物可以并入载体基质中。 该方法提供了对于过氧化活性物质的测试样品的更准确和可靠的测定,并且在用于潜血的尿液测定中特别有用。